Analyst Note on Monster Beverage Corp (NASDAQ:MNST)
Morgan Stanley reiterated its Overweight rating on Monster Beverage Corp and kept its price target at $103 per share. In pre‑market trading the stock rose approximately 0.4% to $98, while Nasdaq 100 futures were up 0.2%.
The brokerage highlighted that innovations introduced since late 2025 now account for roughly 14.5% of the company’s U.S. scanner sales, a sharp rise from virtually zero in September of the previous year. This surge reflects what Morgan Stanley described as the strongest innovation cycle in Monster’s history.
The current product pipeline spans multiple categories beyond traditional flavor extensions. Highlighted launches include the Ultra Red and Blue Razz limited‑edition drinks, Juice Monster Strawberry Lemonade, Strawberry Shots, the FLRT brand aimed at younger female consumers, a relaunch of the Storm line, and U.S. introductions of Lando Norris Zero Sugar and Juice Monster Bad Apple. Many of these items could later be rolled out internationally, where overseas markets already represent nearly half of Monster’s revenue mix.
Scanner data indicate year‑over‑year U.S. market‑share gains in recent weeks, although the firm still expects modest share losses over time. Morgan Stanley believes the broadened innovation strategy will attract new consumers and sales channels while reducing reliance on conventional flavor extensions.
Looking ahead, the analyst maintains forecasts that sit above Wall Street estimates through 2028, citing resilient global demand for energy drinks, continued international share‑gain momentum, an anticipated margin recovery in 2027, and further operational improvements under management’s strategy.
Reporting by Roushni Nair